Paper12379516
Potential therapeutic uses of interleukin 1 receptor antagonists in human diseases.
Hallegua DS and 1 other. Ann Rheum Dis, 2002. Cited by 70 papers, by iCite.
Cite this record
ConductScience Library. Potential therapeutic uses of interleukin 1 receptor antagonists in human diseases. Papers, record 12379516. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/12379516
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antirheumatic Agents | Major topic |
| Arthritis, Rheumatoid | Major topic |
| Interleukin-1 | Major topic |
| Receptors, Interleukin-1 | Major topic |
| Sialoglycoproteins | Major topic |
| Animals | |
| Disease Models, Animal | |
| Humans | |
| Interleukin 1 Receptor Antagonist Protein | |
| Recombinant Proteins |
Source PubMed
References57
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 8294881 | The type II "receptor" as a decoy target for interleukin 1 in polymorphonuclear leukocytes: characterization of induction by dexamethasone and ligand binding properties of the released decoy receptor. | J Exp Med | 1994 | https://conductscience.org/library/papers/8294881 | PubMed |
| 2 | 3106491 | Interferon blocks interleukin 1-induced prostaglandin release from human peripheral monocytes. | J Immunol | 1987 | https://conductscience.org/library/papers/3106491 | PubMed |
| 3 | 8124953 | Initial evaluation of human recombinant interleukin-1 receptor antagonist in the treatment of sepsis syndrome: a randomized, open-label, placebo-controlled multicenter trial. | Crit Care Med | 1994 | https://conductscience.org/library/papers/8124953 | PubMed |
| 4 | 8196140 | Recombinant human interleukin 1 receptor antagonist in the treatment of patients with sepsis syndrome. Results from a randomized, double-blind, placebo-controlled trial. Phase III rhIL-1ra Sepsis Syndrome Study Group. | JAMA | 1994 | https://conductscience.org/library/papers/8196140 | PubMed |
| 5 | 8040288 | Neutralization of endogenous IL-1 receptor antagonist exacerbates and prolongs inflammation in rabbit immune colitis. | J Clin Invest | 1994 | https://conductscience.org/library/papers/8040288 | PubMed |
| 6 | 8049450 | Recombinant human interleukin-1 receptor antagonist in the treatment of steroid-resistant graft-versus-host disease. | Blood | 1994 | https://conductscience.org/library/papers/8049450 | PubMed |
| 7 | 7822808 | Balance of IL-1 receptor antagonist/IL-1 beta in rheumatoid synovium and its regulation by IL-4 and IL-10. | J Immunol | 1995 | https://conductscience.org/library/papers/7822808 | PubMed |
| 8 | 7730651 | A randomized, controlled trial of IL-10 in humans. Inhibition of inflammatory cytokine production and immune responses. | J Immunol | 1995 | https://conductscience.org/library/papers/7730651 | PubMed |
| 9 | 7748221 | Dysregulation of the in vivo production of interleukin-1 receptor antagonist in patients with rheumatoid arthritis. Pathogenetic implications. | Arthritis Rheum | 1995 | https://conductscience.org/library/papers/7748221 | PubMed |
| 10 | 7600191 | Interleukin-1 and interleukin-1 antagonism in sepsis, systemic inflammatory response syndrome, and septic shock. | Shock | 1995 | https://conductscience.org/library/papers/7600191 | PubMed |
| 11 | 7494597 | Microglial interleukin-1 alpha expression in brain regions in Alzheimer's disease: correlation with neuritic plaque distribution. | Neuropathol Appl Neurobiol | 1995 | https://conductscience.org/library/papers/7494597 | PubMed |
| 12 | 8630372 | Biologic basis for interleukin-1 in disease. | Blood | 1996 | https://conductscience.org/library/papers/8630372 | PubMed |
| 13 | 8670316 | Dose-range and dose-frequency study of recombinant human interleukin-1 receptor antagonist in patients with rheumatoid arthritis. The IL-1Ra Arthritis Study Group. | Arthritis Rheum | 1996 | https://conductscience.org/library/papers/8670316 | PubMed |
| 14 | 8839837 | Effects of recombinant soluble type I interleukin-1 receptor on human inflammatory responses to endotoxin. | Blood | 1996 | https://conductscience.org/library/papers/8839837 | PubMed |
| 15 | 8887608 | Expression of interleukin-1 beta (IL-1beta) and interleukin-1 receptor antagonist (IL-1ra) on asthmatic bronchial epithelium. | Am J Respir Crit Care Med | 1996 | https://conductscience.org/library/papers/8887608 | PubMed |
| 16 | 9321530 | A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease. Crohn's Disease cA2 Study Group. | N Engl J Med | 1997 | https://conductscience.org/library/papers/9321530 | PubMed |
| 17 | 9317160 | Constitutive intra-articular expression of human IL-1 beta following gene transfer to rabbit synovium produces all major pathologies of human rheumatoid arthritis. | J Immunol | 1997 | https://conductscience.org/library/papers/9317160 | PubMed |
| 18 | 9361153 | The mechanism of action of methotrexate. | Rheum Dis Clin North Am | 1997 | https://conductscience.org/library/papers/9361153 | PubMed |
| 19 | 9558181 | In vitro effects of diacerhein and rhein on interleukin 1 and tumor necrosis factor-alpha systems in human osteoarthritic synovium and chondrocytes. | J Rheumatol | 1998 | https://conductscience.org/library/papers/9558181 | PubMed |
| 20 | 9597123 | Interleukin-1 receptor antagonist: role in biology. | Annu Rev Immunol | 1998 | https://conductscience.org/library/papers/9597123 | PubMed |
Cited by33
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 70 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42653975 | A Comprehensive Study Utilizing QSAR, Virtual Screening, Molecular Docking, Molecular Dynamics, and MM/GBSA Analyses Reveals Natural Diterpenoids as Promising Caspase-1 Inhibitors. | Molecules | 2026 | https://conductscience.org/library/papers/42653975 | PubMed |
| 40004783 | Mitigating Post-Subarachnoid Hemorrhage Complications: Anti-Inflammatory and Anti-Apoptotic Effects of Anakinra in an Experimental Study. | J Clin Med | 2025 | https://conductscience.org/library/papers/40004783 | PubMed |
| 39939938 | Tear-fluid-derived biomarkers of ocular complications in diabetes: a systematic review and meta-analysis. | BMC Med | 2025 | https://conductscience.org/library/papers/39939938 | PubMed |
| 39355382 | Pilot Study of IL-1 Antagonist Anakinra for Treatment of Endometriosis. | Int J Womens Health | 2024 | https://conductscience.org/library/papers/39355382 | PubMed |
| 38409717 | Analgesic and Anti-inflammatory Potential of the New Tetrahydropyran Derivative (2s,6s)-6-ethyl-tetrahydro-2h-pyran-2-yl) Methanol. | Antiinflamm Antiallergy Agents Med Chem | 2024 | https://conductscience.org/library/papers/38409717 | PubMed |
| 38259483 | Efficacy and safety of anakinra and canakinumab in PSTPIP1-associated inflammatory diseases: a comprehensive scoping review. | Front Immunol | 2023 | https://conductscience.org/library/papers/38259483 | PubMed |
| 37342528 | Pediatric autoinflammatory bone disorders-a mini review with special focus on pathogenesis and inborn errors of immunity. | Front Pediatr | 2023 | https://conductscience.org/library/papers/37342528 | PubMed |
| 36543895 | Tumour necrosis factor alpha, interleukin 1 beta and interferon gamma have detrimental effects on equine tenocytes that cannot be rescued by IL-1RA or mesenchymal stromal cell-derived factors. | Cell Tissue Res | 2023 | https://conductscience.org/library/papers/36543895 | PubMed |
| 34154412 | The Toxoplasma Polymorphic Effector GRA15 Mediates Seizure Induction by Modulating Interleukin-1 Signaling in the Brain. | mBio | 2021 | https://conductscience.org/library/papers/34154412 | PubMed |
| 32998687 | Cytokine profile in the sputum of subjects with post-tuberculosis airflow obstruction and in those with tobacco related chronic obstructive pulmonary disease. | BMC Immunol | 2020 | https://conductscience.org/library/papers/32998687 | PubMed |
| 31102307 | IL-1RA suppresses esophageal cancer cell growth by blocking IL-1α. | J Clin Lab Anal | 2019 | https://conductscience.org/library/papers/31102307 | PubMed |
| 30815434 | Probing Anti-inflammatory Properties Independent of NF-κB Through Conformational Constraint of Peptide-Based Interleukin-1 Receptor Biased Ligands. | Front Chem | 2019 | https://conductscience.org/library/papers/30815434 | PubMed |
| 30392030 | Scoping Review on Use of Drugs Targeting Interleukin 1 Pathway in DIRA and DITRA. | Dermatol Ther (Heidelb) | 2018 | https://conductscience.org/library/papers/30392030 | PubMed |
| 29344744 | Interleukin-1 receptor antagonist inhibits angiogenesis in gastric cancer. | Int J Clin Oncol | 2018 | https://conductscience.org/library/papers/29344744 | PubMed |
| 29137224 | Role of the inflammasome in chronic obstructive pulmonary disease (COPD). | Oncotarget | 2017 | https://conductscience.org/library/papers/29137224 | PubMed |
| 29112534 | Interleukin 1β inhibition contributes to the antinociceptive effects of voluntary exercise on ischemia/reperfusion-induced hypersensitivity. | Pain | 2018 | https://conductscience.org/library/papers/29112534 | PubMed |
| 27358445 | Muscle IL1β Drives Ischemic Myalgia via ASIC3-Mediated Sensory Neuron Sensitization. | J Neurosci | 2016 | https://conductscience.org/library/papers/27358445 | PubMed |
| 26728506 | The effects of transfection reagent polyethyleneimine (PEI) and non-targeting control siRNAs on global gene expression in human aortic smooth muscle cells. | BMC Genomics | 2016 | https://conductscience.org/library/papers/26728506 | PubMed |
| 26611836 | The NLRP3 inflammasome is critically involved in the development of bronchopulmonary dysplasia. | Nat Commun | 2015 | https://conductscience.org/library/papers/26611836 | PubMed |
| 26042735 | Stimulation of Proliferation and Migration of Mouse Macrophages by Type B CpG-ODNs Is F-Spondin and IL-1Ra Dependent. | PLoS One | 2015 | https://conductscience.org/library/papers/26042735 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| IL1A | 3552 | PubTator's text mining | https://conductscience.org/library/genes/3552 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/12379516
GET https://conductscience.org/api/papers/v1/12379516/references?page=2